Meloxicam and Aldactone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Meloxicam (meloxicam) and Aldactone (spironolactone). Common drug interactions include gastrooesophageal reflux disease among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Aldactone. It is created by eHealthMe based on reports of 175 people who take the same drugs from the FDA, and is updated regularly.
What is Meloxicam?
Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.
What is Aldactone?
Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 46,063 Aldactone users. Check the latest studies of Aldactone.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
175 people who take Meloxicam and Aldactone together, and have interactions are studied.
What are the common drug interactions of Meloxicam and Aldactone, by gender? *
What are the common drug interactions of Meloxicam and Aldactone, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Meloxicam and Aldactone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Meloxicam and Aldactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meloxicam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aldactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meloxicam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aldactone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam and spironolactone (the active ingredients of Meloxicam and Aldactone, respectively), and Meloxicam and Aldactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Nortriptyline Hydrochloride and Cymbalta - 4 seconds ago
- Could Tequin cause Ards (Acute Respiratory Distress Syndrome)? - 9 seconds ago
- Could Serzone cause Gastric Ulcer? - 31 seconds ago
- Drug interactions of Macrobid and Ativan - 33 seconds ago
- How effective is Asacol for Crohn'S Disease? - 33 seconds ago
- Could Allopurinol cause Renal Tubular Necrosis? - 51 seconds ago
- Could Tacrolimus cause Dyskinesia Aggravated? - 57 seconds ago
- Cozaar vs. Klor-Con M20, side effect and effectiveness comparison - a minute ago
- Could Symbicort cause Maternal Exposure Before Pregnancy? - a minute ago
- Abdominal Pain Aggravated and Mood Swings - a minute ago